Alterity Therapeutics (ATHE) Gains from Investment Securities (2009 - 2015)
Alterity Therapeutics' (ATHE) quarterly Gains from Investment Securities came in at -$991189.6 in Q4 2015, up 66.21% year-on-year from -$596361.2 in Q4 2014, and up 66.21% quarter-over-quarter from -$2.9 million in Q4 2014.
Alterity Therapeutics (ATHE) Gains from Investment Securities (2009 - 2015) Analysis & Trends
Alterity Therapeutics' Gains from Investment Securities history runs 6 years deep, the most recent figure standing at -$991189.6 for Q4 2015.
- On a quarterly basis, Gains from Investment Securities rose 66.21% year-over-year to -$991189.6 in Q4 2015; TTM through Dec 2015 was -$342.1 billion, a 0.0% change from a year earlier, with the FY2014 full-year figure at -$290.3 billion, down 188307.91% from the prior year.
- Gains from Investment Securities improved to -$991189.6 in Q4 2015 per ATHE's latest filing, from -$2.9 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $158.8 billion in Q2 2011 and bottomed at -$294.8 billion in Q2 2014.
- The 4-year median for Gains from Investment Securities is -$2.0 million (2015), against an average of -$30.6 billion.
- Across the five-year window, Gains from Investment Securities surged 7870882101.13% in 2011 and plunged 129.79% in 2012, its largest moves.
- Year by year, Gains from Investment Securities stood at -$5666.9 in 2011, then plunged by 834452938.45% to -$47.3 billion in 2012, then soared by 99.99% to -$2.9 million in 2014, then surged by 66.21% to -$991189.6 in 2015.
- Per Business Quant, the three latest ATHE Gains from Investment Securities figures stand at -$991189.6 (Q4 2015), -$2.9 million (Q4 2014), and -$294.8 billion (Q2 2014).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alterity Therapeutics | 29.68 Bn | 29.68 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | -991,189.62 |
| Dec 31, 2015 | -991,189.62 |
| Dec 31, 2014 | -2.93 Mn |
| Dec 31, 2014 | -2.93 Mn |
| Jun 30, 2014 | -294.83 Bn |
| Jun 30, 2014 | -294.83 Bn |
| Jun 30, 2012 | -47.29 Bn |
| Jun 30, 2012 | -47.29 Bn |
| Dec 31, 2011 | -5,666.94 |
| Dec 31, 2011 | -5,666.94 |
| Jun 30, 2011 | 158.76 Bn |
| Jun 30, 2011 | 158.76 Bn |
| Dec 31, 2010 | 176,193.00 |
| Dec 31, 2010 | 176,193.00 |
| Jun 30, 2010 | 2,017.00 |
| Jun 30, 2010 | 2,017.00 |
| Dec 31, 2009 | -26,785.00 |
| Dec 31, 2009 | -26,785.00 |
| Jun 30, 2009 | -15,501.00 |
| Jun 30, 2009 | -15,501.00 |